Collegium Pharmaceutical (COLL) Inventory (2016 - 2026)

Collegium Pharmaceutical's Inventory history runs 11 years deep, the most recent figure standing at $42.7 million for Q1 2026.

• On a quarterly basis, Inventory rose 14.84% year-over-year to $42.7 million in Q1 2026; TTM through Mar 2026 was $42.7 million, a 14.84% increase from a year earlier, with the FY2025 full-year figure at $40.9 million, up 15.05% from the prior year.
• Inventory grew to $42.7 million in Q1 2026 per COLL's latest filing, from $40.9 million in the prior quarter.
• Across five years, Inventory topped out at $80.1 million in Q1 2022 and bottomed at $26.0 million in Q2 2023.
• The 5-year median for Inventory is $38.0 million (2024), against an average of $42.6 million.
• Across the five-year window, Inventory soared 417.14% in 2022 and sank 66.53% in 2023, its largest moves.
• Year by year, Inventory stood at $46.5 million in 2022, then slumped by 30.47% to $32.3 million in 2023, then increased by 9.98% to $35.6 million in 2024, then increased by 15.05% to $40.9 million in 2025, then rose by 4.47% to $42.7 million in 2026.
• Per Business Quant, the three latest COLL Inventory figures stand at $42.7 million (Q1 2026), $40.9 million (Q4 2025), and $38.1 million (Q3 2025).